Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Preferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bruker (BRKR) Receivables - Other (2018 - 2026)

Bruker filings provide 8 years of Receivables - Other readings, the most recent being $113.0 million for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 20.73% to $113.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $113.0 million, a 20.73% increase, with the full-year FY2025 number at $113.0 million, up 20.73% from a year prior.
  • Receivables - Other hit $113.0 million in Q4 2025 for Bruker, down from $119.1 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $119.1 million in Q3 2025 to a low of $46.1 million in Q4 2021.
  • Median Receivables - Other over the past 5 years was $79.5 million (2023), compared with a mean of $80.3 million.
  • Biggest five-year swings in Receivables - Other: dropped 4.92% in 2022 and later surged 49.75% in 2023.
  • Bruker's Receivables - Other stood at $46.1 million in 2021, then surged by 32.97% to $61.3 million in 2022, then surged by 34.75% to $82.6 million in 2023, then increased by 13.32% to $93.6 million in 2024, then grew by 20.73% to $113.0 million in 2025.
  • The last three reported values for Receivables - Other were $113.0 million (Q4 2025), $119.1 million (Q3 2025), and $112.4 million (Q2 2025) per Business Quant data.